Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FM34D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,432
Award facts
- Contract value 100% obligated
- $10,431.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on January 5, 2026, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products with a ceiling value of $10,431.53. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 6, 2026, and performance to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a leading biologic immunosuppressant medication used to treat various inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis, serving critical medical supply needs for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company was competitively selected for this delivery order, consistent with its track record of fulfilling federal medical procurement requirements across multiple therapeutic domains through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FM34D?
SPE2DR26FM34D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FM34D worth?
The government has obligated $10,432 on SPE2DR26FM34D.
Is contract SPE2DR26FM34D an order under another contract?
Yes. SPE2DR26FM34D is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM34D competed?
The extent of competition for SPE2DR26FM34D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award